EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cerebrovascular insulin receptors are defective in Alzheimer’s disease

Manon Leclerc, Philippe Bourassa, Cyntia Tremblay, Vicky Caron, Camille Sugère, Vincent Emond, David A Bennett iD, Frédéric Calon iD

Brain · 05.01.2023 · 146 (1) · 75-90

DOI: 10.1093/brain/awac309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 25.10.2022. Verfasst von Manon Leclerc und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculté de Pharmacie, Université Laval, Québec, QC G1V 0A6, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease, Insulin Resistance. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, Canadian Institutes of Health Research, Fonds de recherche du Québec-Santé.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Central response to insulin is suspected to be defective in Alzheimer’s disease. As most insulin is secreted in the bloodstream by the pancreas, its capacity to regulate brain functions must, at least partly, be mediated through the cerebral vasculature. However, how insulin interacts with the blood–brain barrier and whether alterations of this interaction could contribute to Alzheimer’s disease pathophysiology both remain poorly defined. Here, we show that human and murine cerebral insulin receptors (INSRs), particularly the long isoform INSRα-B, are concentrated in microvessels rather than in the parenchyma. Vascular concentrations of INSRα-B were lower in the parietal cortex of subjects diagnosed with Alzheimer’s disease, positively correlating with cognitive scores, leading to a shift towards a higher INSRα-A/B ratio, consistent with cerebrovascular insulin resistance in the Alzheimer’s disease brain. Vascular INSRα was inversely correlated with amyloid-β plaques and β-site APP cleaving enzyme 1, but positively correlated with insulin-degrading enzyme, neprilysin and P-glycoprotein. Using brain cerebral intracarotid perfusion, we found that the transport rate of insulin across the blood–brain barrier remained very low (<0.03 µl/g·s) and was not inhibited by an insulin receptor antagonist. However, intracarotid perfusion of insulin induced the phosphorylation of INSRβ that was restricted to microvessels. Such an activation of vascular insulin receptor was blunted in 3xTg-AD mice, suggesting that Alzheimer’s disease neuropathology induces insulin resistance at the level of the blood–brain barrier. Overall, the present data in post-mortem Alzheimer’s disease brains and an animal model of Alzheimer’s disease indicate that defects in the insulin receptor localized at the blood–brain barrier strongly contribute to brain insulin resistance in Alzheimer’s disease, in association with β-amyloid pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseInsulin ResistanceHumansMiceAnimalsReceptor, InsulinAmyloid beta-PeptidesBrainInsulinDisease Models, Animal

Stichwörter der Autor:innen

Alzheimer’s diseaseblood–brain barrierinsulin receptorinsulin resistance

Substanzen

Receptor, InsulinAmyloid beta-PeptidesInsulin

Autor:innen und Institutionen

  • Faculté de Pharmacie, Université Laval, Québec, QC G1V 0A6, Canada.
  • Axe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Quebec, QC G1V 4G2, Canada.
  • Institut sur la Nutrition et les Aliments Fonctionnels (INAF), Québec, QC G1V 0A6, Canada.
  • Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612, USA.

ORCID-Profile: David A Bennett, Frédéric Calon

Förderung

  • NIA NIH HHS
  • Canadian Institutes of Health Research
  • Fonds de recherche du Québec-Santé
  • Fondation du CHU de Québe
  • Alzheimer Society of Canada
  • Fonds d’Enseignement et de la Recherche
  • Laval University

Zitieren

APA

Leclerc, M., Bourassa, P., Tremblay, C., Caron, V., Sugère, C., Emond, V., Bennett, D. A., & Calon, F. (2023). Cerebrovascular insulin receptors are defective in Alzheimer’s disease. Brain, 146(1), 75-90. https://doi.org/10.1093/brain/awac309

Vancouver

Leclerc M, Bourassa P, Tremblay C, Caron V, Sugère C, Emond V, et al. Cerebrovascular insulin receptors are defective in Alzheimer’s disease. Brain. 2023;146(1):75-90. doi:10.1093/brain/awac309

BibTeX
@article{Leclerc2023,
  author = {Leclerc, Manon and Bourassa, Philippe and Tremblay, Cyntia and Caron, Vicky and Sugère, Camille and Emond, Vincent and Bennett, David A and Calon, Frédéric},
  title = {Cerebrovascular insulin receptors are defective in Alzheimer’s disease},
  journal = {Brain},
  year = {2023},
  volume = {146},
  number = {1},
  pages = {75--90},
  doi = {10.1093/brain/awac309}
}
Kostenlos starten →